| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/23/2006 | CA2579501A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 03/23/2006 | CA2579143A1 Vanilloid receptor ligands and their use in treatments |
| 03/22/2006 | EP1637611A1 Method for producing oligosaccharides |
| 03/22/2006 | EP1637533A1 Substituted thiazolopyrimidines as analgetics |
| 03/22/2006 | EP1637531A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1637164A2 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 03/22/2006 | EP1637162A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637153A1 Product with selective antinflammatory action and antifibrotic properties |
| 03/22/2006 | EP1637139A2 Novel use of HIV protease inhibiting compounds |
| 03/22/2006 | EP1637132A1 External preparation for athlete´s foot treatment |
| 03/22/2006 | EP1636235A1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors |
| 03/22/2006 | EP1636230A2 A1 adenosine receptor antagonists |
| 03/22/2006 | EP1636214A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 03/22/2006 | EP1636204A1 ESTERS OF FLAVONOIDS WITH w-SUBSTITUTED C6-C22 FATTY ACIDS |
| 03/22/2006 | EP1636174A1 Inhibitors of matrix metalloproteinase |
| 03/22/2006 | EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 03/22/2006 | EP1635877A2 Specific high-relaxivity conjugate compounds for magnetic resonance imaging |
| 03/22/2006 | EP1635859A2 Use of pam |
| 03/22/2006 | EP1635829A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
| 03/22/2006 | EP1635824A2 5-membered heterocycle-based p-38 inhibitors |
| 03/22/2006 | EP1635790A1 Pharmaceutical compositions based on diclofenac derivate |
| 03/22/2006 | EP1563083A4 Use of cytokines secreted by dendritic cells |
| 03/22/2006 | EP1472221B1 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 03/22/2006 | EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 03/22/2006 | EP1381620B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 03/22/2006 | EP1368345B1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 03/22/2006 | EP1311522B1 New immunoeffector compounds |
| 03/22/2006 | EP1301516B1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1221963A4 Methods of inhibiting osteoclastogenesis |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | EP1207867B1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | EP0914456B1 Gene expression in monocytes and macrophages |
| 03/22/2006 | CN1751054A Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
| 03/22/2006 | CN1751047A Triazole compounds useful in therapy |
| 03/22/2006 | CN1751042A Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 03/22/2006 | CN1751010A Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 03/22/2006 | CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/22/2006 | CN1750818A Injectable liquid formulation of paracetamol |
| 03/22/2006 | CN1749258A Preparation of polyphenol oxidase model compound and use |
| 03/22/2006 | CN1749257A Platelet activation factor resisting compound |
| 03/22/2006 | CN1748787A Pharmaceutical preparation containing p40 molecule or its gene |
| 03/22/2006 | CN1748783A Dismenorrhea preparation and new preparing method |
| 03/22/2006 | CN1748780A Niuhuang Qingxin dripping pill and its preparing method |
| 03/22/2006 | CN1748767A Lupus preparation and new preparing method |
| 03/22/2006 | CN1748763A Chinese medicine preparation for treating rheumatism stagnation-syndrome pain |
| 03/22/2006 | CN1748758A Dragon's blood gel preparation and its preparing method |
| 03/22/2006 | CN1748757A Dragon's blood external use preparation and its preparing method |
| 03/22/2006 | CN1748753A Waist pain preparation and new preparing method |
| 03/22/2006 | CN1748752A Bone exchanging preparation and new preparing method |
| 03/22/2006 | CN1748746A Chinese medicinal preparation for treating rheumatism, rheumatoid and hyperosteogeny and preparing method |
| 03/22/2006 | CN1748739A Muscle relaxing waist strengthening preparation and new preparing method |
| 03/22/2006 | CN1748737A Xiaojin preparation and new preparing method |
| 03/22/2006 | CN1748736A New medicine administration path for reducing heat and detoxicating injection an dits preparing process |
| 03/22/2006 | CN1748717A Method for prparing bee glue-ethyl cellulose microcapsule |
| 03/22/2006 | CN1748715A Use of Peroplaneta fluligginosa water extract in preparing medicine for anti-inflammatory and immune |
| 03/22/2006 | CN1748702A Newly packed naloxone hydrochloride injection and its producing method |
| 03/22/2006 | CN1246337C Novel TNFR-Fc fusion protein |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246035C Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 03/22/2006 | CN1246010C Rheumatoid disease health recovery admixture |
| 03/22/2006 | CN1246006C Multifunction health therapeutic external use liquid |
| 03/22/2006 | CN1245994C Use of salivary lactobacillus |
| 03/22/2006 | CN1245968C Method for preparing naproxen sodium slow release tablet |
| 03/22/2006 | CN1245967C Use of compound in making medicine |
| 03/22/2006 | CN1245964C Pharmaceutical composition for preventing and treating cancer and treating an inflammation |
| 03/22/2006 | CN1245961C Ultraviolet shielding adhesive preparation |
| 03/21/2006 | US7015325 Alkyne oxy carbamate derivatives used to treat respiratory system disorders |
| 03/21/2006 | US7015237 Pyridine matrix metalloproteinase inhibitors |
| 03/21/2006 | US7015234 Hydroxamic acid derivatives |
| 03/21/2006 | US7015231 such as (3Z)-3-[(1-methyl-1H-indol-3-yl)methylene]-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one; tyrosine kinase inhibitors; for treatment of tumor growth, restenosis, atherosclerosis, pain and thrombosis |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015218 Amide compounds and medicinal use thereof |
| 03/21/2006 | US7015217 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 03/21/2006 | US7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors |
| 03/21/2006 | US7015202 Adjust migration of monocytes, lymphocytes or interleukins; controllinginfections |
| 03/21/2006 | US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 03/21/2006 | US7014853 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 03/21/2006 | US7014841 Delivery of antiemetics through an inhalation route |
| 03/21/2006 | US7014840 heating a thin coating to form a vapor then allowing to cool to form a condensation aerosol; kits |
| 03/21/2006 | US7014652 Methods for treating prostatitis |
| 03/21/2006 | CA2399358C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/21/2006 | CA2315220C Integrin receptor antagonists |
| 03/21/2006 | CA2270887C Methods and compositions for inhibition of angiogenesis |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2178949C Morpholine and thiomorpholine tachykinin receptor antagonists |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/16/2006 | WO2006028875A1 Phenanthridine carbonyl phenols as cytokine modulators |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2006027579A2 The treatment of inflammatory disorders and pain |
| 03/16/2006 | WO2006027365A1 2-substituted-6-trifluoromethyl purine derivatives with adenosine-a3 antagonistic activity |
| 03/16/2006 | WO2006027236A1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 03/16/2006 | WO2006027052A2 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 03/16/2006 | WO2005106488A3 Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2) |